[Leukotrienes and shock].
Oborin
A N
AN
D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine / Q000627:therapeutic use; D000098:Acetophenones / Q000627:therapeutic use; D001095:Arachidonic Acids / Q000378:metabolism*; D012898:Autacoids / Q000037:antagonists & inhibitors; D002867:Chromones / Q000627:therapeutic use; D005231:Fatty Acids, Unsaturated / Q000378:metabolism*; D006801:Humans; D020024:Leukotriene Antagonists; D015289:Leukotrienes / Q000096:biosynthesis*; D013189:SRS-A / Q000037:antagonists & inhibitors; D012769:Shock / Q000188:drug therapy / Q000209:etiology*; D013777:Tetrazoles / Q000627:therapeutic use
D000098:Acetophenones; D001095:Arachidonic Acids; D012898:Autacoids; D002867:Chromones; D005231:Fatty Acids, Unsaturated; D020024:Leukotriene Antagonists; D015289:Leukotrienes; D013189:SRS-A; D013777:Tetrazoles; D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; C044660:LY 171883; C006312:FPL 55712
Leĭkotrieny i shok.